GLP-III · Triple G · LY3437943

Retatrutide

Synthetic triple-agonist peptideWeight & Metabolism

Retatrutide (GLP-III, "Triple G") is a synthetic triple-agonist reference peptide widely studied in metabolic-pathway and energy-balance research. It is supplied as a lyophilized reference standard for in-vitro laboratory use only.

Research context

In published in-vitro research, retatrutide is characterised as a single molecule acting at three receptor targets (GLP-1, GIP and glucagon). This triple-agonism is the focus of metabolic-signalling studies. Peptide Cyprus makes no human-use or efficacy claims.

Research fields

Metabolic-pathway signalling
Energy-balance research models
Receptor triple-agonism studies

Storage & handling

Store lyophilized at −20 °C, protected from light. Reconstitute with bacteriostatic water for laboratory measurement; keep refrigerated at 2–8 °C once reconstituted.

Research use only. This reference material is for in-vitro laboratory research. Not for human or animal consumption.